 "DRUGS, PHARMA SECTOR")
Two years ago, the United States accused China of using coercive methods to transfer technology from US firms to China, as also of outright theft of know-how. Soon, this quarrel morphed into an overall trade-cum-technology war, with escalating tariffs and political rhetoric at high decibel levels. Ever since, speculation has been rife that we are heading towards a “new normal” in global economic relations — where investment and trade links between the US and China are gradually “decoupled”. Other regions of the world have been drawn in, willingly or unwillingly, and the onset of Covid-19 has aggravated the already heated
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper
